Join the 200th Anniversary Celebration

Original Article

Coronary-Artery Vasoconstriction Induced by Cocaine, Cigarette Smoking, or Both

David J. Moliterno, John E. Willard, Richard A. Lange, Brian H. Negus, James D. Boehrer, D. Brent Glamann, Charles Landau, James D. Rossen, Michael D. Winniford, and L. David Hillis

N Engl J Med 1994; 330:454-459February 17, 1994

Abstract

Background

In humans, the use of cocaine and cigarette smoking each increases the heart's metabolic need for oxygen but may also decrease the supply of oxygen. As cocaine abuse has proliferated, cocaine-associated chest pain, myocardial infarction, and sudden death have occurred, especially among smokers. We assessed the influence of intranasal cocaine and cigarette smoking, alone and together, on myocardial oxygen demand and coronary arterial dimensions in subjects with and subjects without coronary atherosclerosis.

Methods

In 42 smokers (28 men and 14 women; age, 34 to 79 years; 36 with angiographically demonstrable coronary artery disease), we measured the product of the heart rate and systolic arterial pressure (rate-pressure product) and coronary arterial diameters before and after intranasal cocaine at a dose of 2 mg per kilogram of body weight (n = 6), one cigarette (n = 12), or intranasal cocaine at a dose of 2 mg per kilogram followed by one cigarette (n = 24).

Results

No patient had chest pain or ischemic electrocardiographic changes after cocaine use or smoking. The mean (±SE) rate-pressure product increased by 11 ±2 percent after cocaine use (n = 30, P<0.001), by 12 ±4 percent after one cigarette (n = 12, P = 0.021), and by 45 ±5 percent after both cocaine use and smoking (n = 24, P<0.001). As compared with base-line measurements, the diameters of nondiseased coronary arterial segments decreased on average by 7 ±1 percent after cocaine use (P<0.001), by 7 ±1 percent after smoking (P<0.001), and by 6 ±2 percent after cocaine use and smoking (P<0.001). The diameters of diseased segments decreased by 9 ±2 percent after cocaine use (n = 18, P<0.001), by 5 ±5 percent after smoking (n = 12, P = 0.322), and by 19 ±4 percent after cocaine use and smoking (n = 12, P<0.001). The increase in the rate-pressure product and the decrease in the diameters of diseased segments caused by cocaine use and smoking together were greater (P<0.001 and P = 0.037, respectively) than the changes caused by either alone.

Conclusions

The deleterious effects of cocaine on myocardial oxygen supply and demand are exacerbated by concomitant cigarette smoking. This combination substantially increases the metabolic requirement of the heart for oxygen but simultaneously decreases the diameter of diseased coronary arterial segments.

Media in This Article

Figure 1Rate-Pressure Product at Base Line, after Cocaine Use, and after Smoking One Cigarette in the 12 Subjects in Group 2 with Coronary Arterial Stenosis.
Figure 2Diameters of Nondiseased (Panel A) and Diseased (Panel B) Segments of Coronary Arteries at Base Line, after Cocaine Use, and after Smoking One Cigarette in the 12 Subjects in Group 2 with Coronary Arterial Stenosis.
Article

Over the past decade, cocaine abuse has become widespread, with over 30 million Americans estimated to have used it1. As its use has escalated, cocaine-associated catastrophic cardiac events, such as acute myocardial infarction and sudden death, have been reported occasionally. Although even small amounts of intranasal cocaine increase the metabolic requirement of the heart for oxygen and decrease the supply of oxygen,2 the mechanisms whereby cocaine abuse sometimes causes cardiac catastrophes are poorly understood.

Previous studies have shown that cigarette smoking also causes a slight increase in myocardial oxygen demand and a concomitant reduction in supply3-8. Other reports have noted that many subjects with cocaine-associated myocardial infarction are cigarette smokers who admit to smoking while using cocaine9. We investigated the hypothesis that the deleterious effects of cocaine and cigarette smoking together might be greater than the effect of either one alone.

Methods

Patient Population

The data were obtained in 42 smokers (28 men and 14 women, 34 to 79 years of age) undergoing elective cardiac catheterization for the evaluation of chest pain. None had an unstable cardiac condition, recent myocardial infarction, or other acute medical illness, and none admitted to previous cocaine use. Of the 42 subjects, 6 had angiographically normal coronary arteries, 15 had coronary artery disease affecting a single vessel ( ≥ 70 percent narrowing of the luminal diameter of a major epicardial coronary artery), 14 had disease involving two vessels, and 7 had disease involving three vessels. The protocols were approved by the Human Subjects Review committees of the University of Texas Southwestern Medical Center and the University of Iowa Hospitals, and all subjects gave written, informed consent. We have administered intranasal cocaine, at a dose of 2 mg per kilogram of body weight, to more than 100 study patients,2,10-14 and none have had adverse sequelae. Antianginal medications (beta-blockers, calcium-channel blockers, and long-acting nitrates) were discontinued 24 hours before the study. All subjects were studied between 8 a.m. and 10 a.m. after an overnight fast and received 5 mg of oral diazepam approximately 60 minutes before the procedure. All subjects refrained from smoking for more than 12 hours before the study.

Experimental Protocol

A 9-French arterial sheath was inserted percutaneously into the femoral artery, through which an 8-French Judkins catheter was advanced to the ostium of the left coronary artery. Systemic arterial pressure was monitored through the sheath's side-port extension, and the heart rate was determined electrocardiographically. All coronary angiography was performed with non-ionic contrast material, with 9 to 10 ml given over a period of three seconds. Cineangiography of the left coronary artery was performed to exclude disease of the left main segment and was followed by cineangiography of the left anterior descending or circumflex coronary artery in the right anterior oblique projection with cranial or caudal angulation, respectively. In each patient, the artery that was optimally opacified and rendered free of foreshortening and overlapping adjacent vessels was selected.

In the initial 30 patients (18 men and 12 women, 34 to 66 years of age), base-line hemodynamic recordings were obtained and cineangiography was performed, after which each received intranasal cocaine hydrochloride (10 percent solution, Roxane Laboratories, Columbus, Ohio) at a dose of 2 mg per kilogram, according to methods described previously2. This dose is smaller than that consumed during most illicit use14. Fifteen minutes later, hemodynamic measurements and cineangiography were repeated, and a blood sample was collected in an iced tube containing sodium fluoride for the measurement of the cocaine concentration. During the subsequent five minutes, 24 of these 30 subjects were assigned by a random drawing to smoke one cigarette (group 2), whereas the other 6 were assigned randomly to wait without smoking (group 1, the controls). Then, hemodynamic measurements and cineangiography were repeated. In these 30 subjects, therefore, myocardial oxygen demand and the dimensions of epicardial coronary arteries were assessed at base line, 15 minutes after intranasal cocaine, and immediately after one cigarette had been smoked (20 minutes after cocaine use) or no cigarettes had been smoked. We have previously observed that smoking-induced vasoconstriction of the epicardial coronary arteries is short-lived, since it is maximal 5 minutes after smoking and resolves within 15 minutes15. On the basis of these data, we thought the subjects should not smoke before receiving intranasal cocaine, since the influence of the former would have resolved by the time the latter began to exert its vasoconstrictive effect.

After the initial 30 subjects were studied as described above, 12 additional subjects (10 men and 2 women, 42 to 79 years of age) (group 3) with a stenosis of the left anterior descending (n = 7) or circumflex (n = 5) coronary artery were enrolled consecutively. In these 12, heart rate, systemic arterial pressure, and coronary arterial diameter were measured at base line and immediately after one cigarette had been smoked.

Variables Assessed

In each subject, heart rate as well as systolic and mean arterial pressures were measured at each time noted. In all 42 subjects, a segment of the proximal, middle, and distal left anterior descending or circumflex coronary artery that appeared free of atherosclerotic narrowing was identified for quantitative analysis, as described below. In the 30 subjects with atherosclerotic narrowing of the left anterior descending or circumflex coronary artery (6 from group 1, 12 from group 2, and 12 from group 3), the dimensions of each stenosis were analyzed in a similar fashion. We performed all quantitative coronary analyses without knowledge of the subject's group assignment. Cine frames were selected at comparable points in the cardiac cycle, and computer-assisted analysis (Cardiovascular Angiography Analysis System, Pie Medical, Maastricht, the Netherlands) was performed according to methods described previously2,10-13,16. Arterial segments were digitized from the 35-mm cine film and optically magnified. The contours of the selected vessel regions were detected automatically by the computer on the basis of the weighted sums of the first and second derivative functions applied to the digitized image. Contour data were corrected for pincushion distortion, and the absolute dimensions of the vessel were determined with the use of the coronary catheter for calibration. The luminal diameter of each nondiseased and diseased arterial segment was determined. We have had extensive experience with quantitative coronary arteriography2,10-13,15; the variability of this analysis in our laboratories is similar to that previously reported16.

Statistical Analysis

All data are reported as the means ±1 SE. The changes in the product of the heart rate and systolic arterial pressure (the rate-pressure product) and in the diameters of the coronary arteries among the three groups were compared by analysis of variance. We performed hemodynamic and arteriographic analyses without knowledge of the subject's group assignment. For the 30 subjects who received cocaine (groups 1 and 2), the effect of cocaine on the heart rate, systemic arterial pressure, the rate-pressure product, and coronary arterial diameter was assessed with a paired t-test17. For the 12 subjects who smoked one cigarette (group 3), the effect of smoking on these variables was also assessed with a paired t-test17. To test the influence of smoking in the 24 subjects in group 2 who received cocaine, a paired t-test was used to compare each variable after cocaine use and after smoking. The effect of not smoking was assessed in a similar manner for the six subjects in group 1. For all analyses, a two-tailed P value of less than 0.05 was considered to indicate statistical significance.

Results

None of the subjects had chest pain or electrocardiographic changes consistent with the occurrence of myocardial ischemia after cocaine ingestion or cigarette smoking. In the 30 subjects who received cocaine (groups 1 and 2), the serum cocaine concentration averaged 0.12 ±0.01 mg per liter (range, 0.03 to 0.27). In these subjects, the rate-pressure product -- a reflection of myocardial oxygen demand -- increased 11 ±2 percent with cocaine use (P<0.001) (Table 1Table 1Hemodynamic Data on the Three Groups of Smokers.). There was no further change in the rate-pressure product in the six subjects who did not smoke within 20 minutes after cocaine use (group 1). In contrast, the rate-pressure product increased markedly in the 24 subjects who smoked after cocaine administration (group 2), so that it was 45 ±5 percent above base line (Table 1). This increase was significantly greater (P<0.001) than that produced by cocaine use alone (group 1) or smoking alone (group 3) (Table 1 and Figure 1Figure 1Rate-Pressure Product at Base Line, after Cocaine Use, and after Smoking One Cigarette in the 12 Subjects in Group 2 with Coronary Arterial Stenosis.).

In the 30 subjects who received intranasal cocaine (groups 1 and 2), cocaine caused a 7 ±1 percent decrease in the diameter of nondiseased segments of the left anterior descending or circumflex coronary arteries (P<0.001). The data on all nondiseased segments are shown in Table 2Table 2Dimensions of Nondiseased Segments of Coronary Arteries.. These dimensions were not further altered by a five-minute wait in group 1 or by smoking one cigarette in group 2 (Table 2 and Figure 2AFigure 2Diameters of Nondiseased (Panel A) and Diseased (Panel B) Segments of Coronary Arteries at Base Line, after Cocaine Use, and after Smoking One Cigarette in the 12 Subjects in Group 2 with Coronary Arterial Stenosis.). In contrast, smoking produced a further vasoconstrictive effect in addition to that induced by cocaine in coronary arterial segments narrowed by atherosclerosis. As the data in Table 3Table 3Dimensions of Diseased Segments of Coronary Arteries. indicate, cocaine induced a 9 ±2 percent decline in coronary arterial diameter (groups 1 and 2). This dimension was unchanged after a five-minute wait in group 1, but it was decreased further after one cigarette in group 2, so that the combination of cocaine use and smoking produced a 19 ±4 percent decline in the diameter of diseased segments of coronary arteries (Table 3 and Figure 2B and Figure 3Figure 3Arteriograms of the Left Circumflex Coronary Artery in the Right Anterior Oblique Projection at Base Line (Panel A), after Intranasal Cocaine (Panel B), and after One Cigarette (Panel C).). This decrease was greater (P = 0.037) than that observed in diseased segments in response to cocaine use alone (group 1) or smoking alone (group 3) (Table 3).

Discussion

As cocaine abuse has proliferated, the incidence of catastrophic cardiovascular events related to cocaine use has increased. Most patients in whom myocardial infarction or sudden death occur are young or middle-aged men who are smokers and who smoke while using cocaine, and the majority have angiographic or postmortem evidence of coronary artery disease9. Cocaine produces adrenergic stimulation by blocking the presynaptic reuptake of norepinephrine and dopamine, leading to an excessive amount of these substances at postsynaptic receptor sites. This adrenergic stimulation increases the heart rate, blood pressure, and left ventricular contractility, so that the metabolic requirement of the heart for oxygen increases14. Concomitantly, myocardial oxygen supply declines because of cocaine-induced vasoconstriction of the coronary arteries2,10-13. Similarly, within minutes of cigarette smoking, nicotinic receptors in the adrenal medulla are stimulated, triggering the release of epinephrine and norepinephrine18. As a result, heart rate and left ventricular contractility increase, leading to an increase in the requirement of the myocardium for oxygen3-5. Despite this increase in the need for oxygen, smoking -- like cocaine use -- has been shown to cause vasoconstriction of angiographically normal and diseased segments of coronary arteries7,15. In short, cocaine use and cigarette smoking each increase myocardial oxygen demand and simultaneously reduce oxygen supply. Since cocaine abusers often smoke while they are ingesting cocaine, this study was performed to assess the influence of the combination of intranasal cocaine and cigarette smoking on myocardial oxygen supply and demand.

Our data, obtained in 42 smokers studied during cardiac catheterization, show that myocardial oxygen demand (measured as the product of the heart rate and systolic arterial pressure) increased with cocaine use or smoking. However, oxygen demand increased much more with the combination of cocaine ingestion and smoking than with either one alone. As we have shown previously,2,10-13,15 each of these factors induced slight vasoconstriction in angiographically normal segments of coronary arteries, and smoking did not influence the magnitude of vasoconstriction in these segments in the 24 subjects who received cocaine (group 2). In contrast, diseased segments of coronary arteries narrowed 9 ±2 percent with cocaine use, and smoking induced a further decline in the diameter of coronary arteries. The magnitude of the reduction in the diameter caused by cocaine use and smoking (19 ±4 percent) was greater than that caused by either cocaine use or smoking alone.

Although little is known about the effect of cocaine use or smoking on vascular endothelium, their vasoconstrictive effect is mediated, at least in part, by alpha-adrenergic stimulation, since it is alleviated by phentolamine, an alpha-adrenergic-blocking agent2,19. The integrity of the coronary arterial endothelium may influence the vasomotor response that occurs with cocaine use, cigarette smoking, and their combination. Smoking has been shown to injure endothelial cells20 and reduce prostacyclin production21,22. Each has been shown to induce vasoconstriction in angiographically normal and diseased segments of coronary arteries; at the same time, each causes more intense vasoconstriction in diseased than nondiseased segments, suggesting that the presence of functioning endothelium may attenuate cocaine-induced or smoking-induced vasoconstriction. In the 72 nondiseased segments of coronary arteries in our 24 subjects who smoked after cocaine use (group 2), cocaine-induced vasoconstriction was not consistently worsened by smoking, although the diameter of the coronary arteries decreased by more than 10 percent in a total of six segments in 5 of these subjects. In contrast, smoking produced an additional vasoconstrictive effect in the 12 diseased segments from the same subjects.

Our study has limitations. First, we assessed the effect of a dose of only 2 mg of intranasal cocaine per kilogram followed by only one cigarette. Although the effect of cocaine when given by other routes (i.e., inhalation or intravenous injection) may be different, most reported cases of cocaine-associated myocardial infarction have occurred after its intranasal administration. The dose of cocaine that we used is smaller than that usually consumed during illicit use, and the exact amount of smoke inhaled from only one cigarette was not measured. Perhaps the combined effect of larger amounts of cocaine and cigarette smoke would produce an even greater increase in myocardial oxygen demand and a larger decrease in coronary arterial dimensions. Furthermore, it is conceivable that larger amounts of cocaine and cigarette smoke may induce vasoconstriction in nondiseased segments of coronary arteries in an occasional subject. As noted previously, smoking caused an additional decrease of more than 10 percent in the diameter of six nondiseased coronary arterial segments from five subjects in group 2. Second, we examined the effects of cocaine use and smoking 20 minutes after the former and immediately after the latter; therefore, we have no data regarding their effects on the rate-pressure product and coronary arterial dimensions at other times. Third, all 24 subjects in group 2 first received intranasal cocaine and then smoked a cigarette. No patient smoked a cigarette and then ingested cocaine. Since vasoconstriction of epicardial coronary arteries is maximal five minutes after smoking,15 its influence would have waned by the time intranasal cocaine exerted its vasoconstrictive effect.

With these caveats in mind, we conclude that intranasal cocaine in combination with cigarette smoking causes a substantial increase in myocardial oxygen demand and a decrease in the diameter of coronary arterial segments narrowed by atherosclerosis. We suggest that in an occasional subject, a larger amount of cocaine in combination with smoking might induce an even greater increase in myocardial oxygen demand and a larger decrease in coronary arterial dimensions, culminating in myocardial ischemia, infarction, or sudden cardiac death.

We are indebted to Sheila De Paola, Kelly Heathman, Jacqui Jones, Jeanette Kissee, Marsha Pecena, Karen Scherger, and Nancy Smith for technical assistance and to Shelly K. Sapp for statistical assistance.

Source Information

From the Department of Internal Medicine, Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.J.M., J.E.W., R.A.L., B.H.N., J.D.B., D.B.G., C.L., L.D.H.), and the Department of Internal Medicine, Cardiovascular Division, University of Iowa, Iowa City (J.D.R., M.D.W.).

Address reprint requests to Dr. Hillis at Rm. CS 7.102, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9047.

References

References

  1. 1

    Annual data 1987: data from the Drug Abuse Warning Network. Ser. 1, No. 7 of National Institute on Drug Abuse statistical series. Rockville, Md.: National Institute on Drug Abuse, 1988. (DHHS publication no. (ADM) 88-1584).

  2. 2

    Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989;321:1557-1562
    Full Text | Web of Science | Medline

  3. 3

    Thomas CB, Bateman JL, Lindberg EF. Observations on the individual effects of smoking on the blood pressure, heart rate, stroke volume and cardiac output of healthy young adults. Ann Intern Med 1956;44:874-892
    Web of Science | Medline

  4. 4

    Rabinowitz BD, Thorp K, Huber GL, Abelmann WH. Acute hemodynamic effects of cigarette smoking in man assessed by systolic time intervals and echocardiography. Circulation 1979;60:752-760
    Web of Science | Medline

  5. 5

    Nicod P, Rehr R, Winniford MD, Campbell WB, Firth BG, Hillis LD. Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. J Am Coll Cardiol 1984;4:964-971
    CrossRef | Web of Science | Medline

  6. 6

    Maouad J, Fernandez F, Hebert JL, Zamani K, Barrillon A, Gay J. Cigarette smoking during coronary angiography: diffuse or focal narrowing (spasm) of the coronary arteries in 13 patients with angina at rest and normal coronary angiograms. Cathet Cardiovasc Diagn 1986;12:366-375
    CrossRef | Medline

  7. 7

    Moreyra AE, Lacy CR, Wilson AC, Kumar A, Kostis JB. Arterial blood nicotine concentration and coronary vasoconstrictive effect of low-nicotine cigarette smoking. Am Heart J 1992;124:392-397
    CrossRef | Web of Science | Medline

  8. 8

    Klein LW, Ambrose J, Pichard A, Holt J, Gorlin R, Teichholz LE. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol 1984;3:879-886
    CrossRef | Web of Science | Medline

  9. 9

    Minor RL Jr, Scott BD, Brown DD, Winniford MD. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991;115:797-806
    Web of Science | Medline

  10. 10

    Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990;112:897-903
    Web of Science | Medline

  11. 11

    Flores ED, Lange RA, Cigarroa RG, Hillis LD. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol 1990;16:74-79
    CrossRef | Web of Science | Medline

  12. 12

    Brogan WC III, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991;18:581-586
    CrossRef | Web of Science | Medline

  13. 13

    Brogan WC III, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 1992;116:556-561
    Web of Science | Medline

  14. 14

    Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol 1992;20:90-93
    CrossRef | Web of Science | Medline

  15. 15

    Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez AG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993;22:642-647
    CrossRef | Web of Science | Medline

  16. 16

    Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-288
    CrossRef | Web of Science | Medline

  17. 17

    Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971:185-96.

  18. 18

    Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577
    Full Text | Web of Science | Medline

  19. 19

    Kuhn FE, Johnson MN, Gillis RA, Visner MS, Schaer GL. Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs. J Am Coll Cardiol 1990;16:1481-1491
    CrossRef | Web of Science | Medline

  20. 20

    Zimmerman M, McGeachie J. The effect of nicotine on aortic endothelium: a quantitative ultrastructural study. Atherosclerosis 1987;63:33-41
    CrossRef | Web of Science | Medline

  21. 21

    Sonnenfeld T, Wennmalm A. Inhibition by nicotine of the formation of prostacyclin-like activity in rabbit and human vascular tissue. Br J Pharmacol 1980;71:609-613
    Web of Science | Medline

  22. 22

    Reinders JH, Brinkman HJ, van Mourik JA, de Groot PG. Cigarette smoke impairs endothelial cell prostacyclin production. Arteriosclerosis 1986;6:15-23
    CrossRef | Medline

Citing Articles (69)

Citing Articles

  1. 1

    J. B. Finkel, G. D. Marhefka. (2011) Rethinking Cocaine-Associated Chest Pain and Acute Coronary Syndromes. Mayo Clinic Proceedings 86:12, 1198-1207
    CrossRef

  2. 2

    Jeffrey Green, Richard Harrigan. 2011. Cardiac Toxins and Drug-Induced Heart Disease. , 237-257.
    CrossRef

  3. 3

    C. Dechanet, C. Brunet, T. Anahory, S. Hamamah, B. Hedon, H. Dechaud. (2011) Effet du tabagisme sur l’implantation embryonnaire et la placentation précoce et facteurs influençant la toxicité tabagique sur la reproduction (Partie II). Gynécologie Obstétrique & Fertilité 39:10, 567-574
    CrossRef

  4. 4

    Khaldoon Shaheen, M. Chadi Alraies, Houssam Marwany, Emmanuel Elueze. (2011) Illicit Drug, Ischemic Bowel. The American Journal of Medicine 124:8, 708-710
    CrossRef

  5. 5

    C. Dechanet, T. Anahory, J. C. Mathieu Daude, X. Quantin, L. Reyftmann, S. Hamamah, B. Hedon, H. Dechaud. (2011) Effects of cigarette smoking on reproduction. Human Reproduction Update 17:1, 76-95
    CrossRef

  6. 6

    Sazzli Kasim, Ronan O'Donabhain, Eugene Mcfadden. (2011) Cocaine-Associated Myocardial Infarction: Should They All Be Stented?. Case Reports in Cardiology 2011, 1-2
    CrossRef

  7. 7

    Rahel Alemu, Eileen E. Fuller, John F. Harper, Mark Feldman. (2011) Influence of Smoking on the Location of Acute Myocardial Infarctions. ISRN Cardiology 2011, 1-3
    CrossRef

  8. 8

    John C.M. Brust. 2011. Stroke and Substance Abuse. , 790-813.
    CrossRef

  9. 9

    Xavier Bosch, Pablo Loma-Osorio, Eduard Guasch, Santiago Nogué, José T. Ortiz, Miquel Sánchez. (2010) Prevalencia, características clínicas y riesgo de infarto de miocardio en pacientes con dolor torácico y consumo de cocaína. Revista Española de Cardiología 63:9, 1028-1034
    CrossRef

  10. 10

    Alan H. Gradman, Nosheen Javed. 2010. Addictive Disorders in Cardiovascular Medicine. , 251-275.
    CrossRef

  11. 11

    Yvonne M. Hunt, Carla J. Rash, Randy S. Burke, Jefferson D. Parker. (2010) Smoking Cessation in Recovery: Comparing 2 Different Cognitive Behavioral Treatments. Addictive Disorders & Their Treatment 9:2, 64-74
    CrossRef

  12. 12

    J. Lucena, M. Blanco, C. Jurado, A. Rico, M. Salguero, R. Vazquez, G. Thiene, C. Basso. (2010) Cocaine-related sudden death: a prospective investigation in south-west Spain. European Heart Journal 31:3, 318-329
    CrossRef

  13. 13

    R. A. Lange, L. D. Hillis. (2010) Sudden death in cocaine abusers. European Heart Journal 31:3, 271-273
    CrossRef

  14. 14

    Theodore V. Cooper, Yvonne M. Hunt, Randy S. Burke, Colby J. Stoever. (2009) Assessing a Smoking Cessation Intervention for Veterans in Substance Use Disorder Treatment. Addictive Disorders & Their Treatment 8:4, 167-174
    CrossRef

  15. 15

    Kevin B. Freeman, William L. Woolverton. (2009) Self-administration of cocaine and nicotine mixtures by rhesus monkeys. Psychopharmacology 207:1, 99-106
    CrossRef

  16. 16

    Suresh Krishnamoorthy, Gregory Y.H. Lip, Deirdre A. Lane. (2009) Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review. The American Journal of Medicine 122:9, 851-856.e3
    CrossRef

  17. 17

    Kamakshi V. Gopal, Richard Herrington, Jacquelin Pearce. (2009) Analysis of Auditory Measures in Normal Hearing Young Male Adult Cigarette Smokers Using Multiple Variable Selection Methods with Predictive Validation Assessments. International Journal of Otolaryngology 2009, 1-7
    CrossRef

  18. 18

    Carlos S. Restrepo, Carlos A. Rojas, Santiago Martinez, Roy Riascos, Alejandro Marmol-Velez, Jorge Carrillo, Daniel Vargas. (2009) Cardiovascular complications of cocaine: Imaging findings. Emergency Radiology 16:1, 11-19
    CrossRef

  19. 19

    Tamam Mohamad, Ashok Kondur, Peter Vaitkevicius, Khaled Bachour, Deepak Thatai, Luis Afonso. (2008) Cocaine-Induced Chest Pain and β-Blockade: An Inner City Experience. American Journal of Therapeutics 15:6, 531-535
    CrossRef

  20. 20

    Loukianos S. Rallidis, John Lekakis, Demosthenes Panagiotakos, Katerina Fountoulaki, Christoforos Komporozos, Thomas Apostolou, Ioannis Rizos, Dimitrios T. Kremastinos. (2008) Long-term prognostic factors of young patients (≤35 years) having acute myocardial infarction: the detrimental role of continuation of smoking. European Journal of Cardiovascular Prevention & Rehabilitation 15:5, 567-571
    CrossRef

  21. 21

    Steve Leung, Dianne Gallup, Kenneth W. Mahaffey, Marc Cohen, Elliott M. Antman, Shaun G. Goodman, Robert A. Harrington, Anatoly Langer, Philip Aylward, James J. Ferguson, Robert M. Califf. (2008) Smoking status and antithrombin therapy in patients with non–ST-segment elevation acute coronary syndrome. American Heart Journal 156:1, 177-184
    CrossRef

  22. 22

    Omer Alyan, Fehmi Kacmaz, Ozcan Ozdemir, Orhan Maden, Serkan Topaloglu, Cemal Ozbakir, Fatma Metin, Aziz Karadede, Erdogan Ilkay. (2008) Effects of Cigarette Smoking on Heart Rate Variability and Plasma N-Terminal Pro-B-Type Natriuretic Peptide in Healthy Subjects: Is There the Relationship between Both Markers?. Annals of Noninvasive Electrocardiology 13:2, 137-144
    CrossRef

  23. 23

    Norihiko Shinozaki, Toyoshi Yuasa, Shigeo Takata. (2008) Cigarette Smoking Augments Sympathetic Nerve Activity in Patients With Coronary Heart Disease. International Heart Journal 49:3, 261-272
    CrossRef

  24. 24

    Sarabjeet Singh, Atul Trivedi, Tara Adhikari, Janos Molnar, Rohit Arora, Sandeep Khosla. (2007) Cocaine-related acute aortic dissection: Patient demographics and clinical outcomes. Canadian Journal of Cardiology 23:14, 1131-1134
    CrossRef

  25. 25

    Luis Afonso, Tamam Mohammad, Deepak Thatai. (2007) Crack Whips the Heart: A Review of the Cardiovascular Toxicity of Cocaine. The American Journal of Cardiology 100:6, 1040-1043
    CrossRef

  26. 26

    Marc J. Kaufman, Chris C. Streeter, Tanya L. Barros, Ofra Sarid-Segal, Maryam Afshar, Hua Tian, Elizabeth D. Rouse, Karen K. B. Foy, Melanie L. Brimson, Courtney A. Archambault, Perry F. Renshaw, Domenic A. Ciraulo. (2007) Reduced Plasma Nitric Oxide End Products in Cocaine-dependent Men. Journal of Addiction Medicine 1:2, 96-103
    CrossRef

  27. 27

    John C.M. Brust. 2007. Cocaïne. , 171-243.
    CrossRef

  28. 28

    John C.M. Brust. 2007. Tabac. , 519-550.
    CrossRef

  29. 29

    James H. Jones, William B. Weir. (2005) Cocaine-Associated Chest Pain. Medical Clinics of North America 89:6, 1323-1342
    CrossRef

  30. 30

    Joel T. Levis, Gus M. Garmel. (2005) Cocaine-Associated Chest Pain. Emergency Medicine Clinics of North America 23:4, 1083-1103
    CrossRef

  31. 31

    Ayrn D. O'Connor, Daniel E. Rusyniak, Askiel Bruno. (2005) Cerebrovascular and Cardiovascular Complications of Alcohol and Sympathomimetic Drug Abuse. Medical Clinics of North America 89:6, 1343-1358
    CrossRef

  32. 32

    Damaris J. Rohsenow, Suzanne M. Colby, Rosemarie A. Martin, Peter M. Monti. (2005) Nicotine and other substance interaction expectancies questionnaire: Relationship of expectancies to substance use. Addictive Behaviors 30:4, 629-641
    CrossRef

  33. 33

    Shane Darke, Sharlene Kaye, Johan Duflou. (2005) Cocaine-related fatalities in New South Wales, Australia 1993–2002. Drug and Alcohol Dependence 77:2, 107-114
    CrossRef

  34. 34

    Katherine R. Schlaerth, Robert G. Splawn, Julienne Ong, Stephen D. Smith. (2004) Change in the Pattern of Illegal Drug Use in an Inner City Population Over 50. Journal of Addictive Diseases 23:2, 95-107
    CrossRef

  35. 35

    John C.M. Brust. 2004. Stroke and Substance Abuse. , 725-745.
    CrossRef

  36. 36

    Azra Mahmud, John Feely. (2004) Effects of passive smoking on blood pressure and aortic pressure waveform in healthy young adults - influence of gender. British Journal of Clinical Pharmacology 57:1, 37-43
    CrossRef

  37. 37

    Fabienne Moritz, Christelle Monteil, Paul Mulder, Geneviève Derumeaux, Catherine Bizet, Sylvanie Renet, Françoise Lallemand, Vincent Richard, Christian Thuillez. (2003) Prolonged Cardiac Dysfunction After Withdrawal of Chronic Cocaine Exposure in Rats. Journal of Cardiovascular Pharmacology 42:5, 642-647
    CrossRef

  38. 38

    Wendy J Mack, Talat Islam, Zenaida Lee, Robert H Selzer, Howard N Hodis. (2003) Environmental tobacco smoke and carotid arterial stiffness. Preventive Medicine 37:2, 148-154
    CrossRef

  39. 39

    Mark M Knuepfer. (2003) Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacology & Therapeutics 97:3, 181-222
    CrossRef

  40. 40

    Anurag Mehta, Abnash C. Jain, Mahaveer C. Mehta. (2003) Electrocardiographic Effects of Intravenous Cocaine: An Experimental Study in a Canine Model. Journal of Cardiovascular Pharmacology 41:1, 25-30
    CrossRef

  41. 41

    Askiel Bruno. (2003) Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Current Neurology and Neuroscience Reports 3:1, 40-45
    CrossRef

  42. 42

    Maria A. Sullivan, Lirio S. Covey. (2002) Current perspectives on smoking cessation among substance abusers. Current Psychiatry Reports 4:5, 388-396
    CrossRef

  43. 43

    Mahaveer C. Mehta, Abnash C. Jain, Mike Billie. (2002) Effects of Cocaine and Alcohol Alone and in Combination on Cardiovascular Performance in Dogs. The American Journal of the Medical Sciences 324:2, 76-83
    CrossRef

  44. 44

    Maria Del Ben, Daniela Maccioni, Antongiulio Scarno, Alfredo Scorza, Cesare Alessandri. (2001) Cocaine use and acute coronary syndromes. The Lancet 358:9290, 1369
    CrossRef

  45. 45

    Mahaveer C. Mehta, Abnash C. Jain, Mike Billie. (2001) Combined effects of cocaine and nicotine on cardiovascular performance in a canine model. Clinical Cardiology 24:9, 620-626
    CrossRef

  46. 46

    Lange, Richard A., Hillis, L. David, . (2001) Cardiovascular Complications of Cocaine Use. New England Journal of Medicine 345:5, 351-358
    Full Text

  47. 47

    Constantinos G Missouris, Pauline A Swift, Donald RJ Singer. (2001) Cocaine use and acute left ventricular dysfunction. The Lancet 357:9268, 1586
    CrossRef

  48. 48

    E. Roig, G. Melis, M. Heras, M. Rigol, F. Epelde, G. DeCandia, G. Sanz. (2000) Nitric oxide inhibition intensifies the depressant effect of cocaine on the left ventricular function in anaesthetized pigs. European Journal of Clinical Investigation 30:11, 957-963
    CrossRef

  49. 49

    Sunagawa Osahiko, Shinzato Yuzuru, Touma Takashi, Tomori Masayuki, Fukiyama Koshiro. (2000) Differences between Coronary Hyperresponsiveness to Ergonovine and Vasospastic Angina.. Japanese Heart Journal 41:3, 257-268
    CrossRef

  50. 50

    Knud Landmark, Michael Abdelnoor. (2000) Current Smokers Develop More Posterior Myocardial Infarctions Probably Due to Increased Tendency to Thrombosis. Scandinavian Cardiovascular Journal 34:1, 73-78
    CrossRef

  51. 51

    Cynthia A. Dirkx, Eugenio O. Gerscovich. (1998) Sonographic findings in methamphetamine-induced ischemic colitis. Journal of Clinical Ultrasound 26:9, 479-482
    CrossRef

  52. 52

    Dominick L. Frosch, Steve Shoptaw, Murray E. Jarvik, Richard A. Rawson, Walter Ling. (1998) Interest in Smoking Cessation Among Methadone Maintained Outpatients. Journal of Addictive Diseases 17:2, 9-19
    CrossRef

  53. 53

    R HOFFMAN, J HOLLANDER. (1997) EVALUATION OF PATIENTS WITH CHEST PAIN AFTER COCAINE USE. Critical Care Clinics 13:4, 809-828
    CrossRef

  54. 54

    C Vyssier Belot. (1997) Consommation de tabac et risque cardiovasculaire. La Revue de Médecine Interne 18:9, 702-708
    CrossRef

  55. 55

    KENNETH A. PERKINS. (1997) Combined effects of nicotine and alcohol on subjective, behavioral and physiological responses in humans. Addiction Biology 2:3, 255-268
    CrossRef

  56. 56

    Hedy H. Boutros, Stephen Pautler, Subrata Chakrabarti. (1997) Cocaine-Induced Ischemic Colitis with Small-Vessel Thrombosis of Colon and Gallbladder. Journal of Clinical Gastroenterology 24:1, 49-53
    CrossRef

  57. 57

    Thomas A. Burling, Timothy G. Ramsey, Andrea L. Seidner, Christine S. Kondo. (1997) Issues related to smoking cessation among substance abusers. Journal of Substance Abuse 9, 27-40
    CrossRef

  58. 58

    Markus Haass, Wolfgang Kbler. (1997) Nicotine and sympathetic neurotransmission. Cardiovascular Drugs and Therapy 10:6, 657-665
    CrossRef

  59. 59

    Joan G. Meeder, Paul K. Blanksma, Ernst E. Wall, Rutger L. Anthonio, Antoon T. M. Willemsen, Jan Pruim, Wim Vaalburg, Kong I. Lie. (1996) Long-term cigarette smoking is associated with increased myocardial perfusion heterogeneity assessed by positron emission tomography. European Journal of Nuclear Medicine 23:11, 1442-1447
    CrossRef

  60. 60

    Frank LoVecchio, Lewis Nelson. (1996) Intraventricular bleeding after the use of thrombolytics in a cocaine user. The American Journal of Emergency Medicine 14:7, 663-664
    CrossRef

  61. 61

    Wood, Alastair J.J., , Mendelson, Jack H., Mello, Nancy K., . (1996) Management of Cocaine Abuse and Dependence. New England Journal of Medicine 334:15, 965-972
    Full Text

  62. 62

    Stuart I. Myers, G. Patrick Clagett, R. James Valentine, Margaret E. Hansen, Aditi Anand, Arun Chervu. (1996) Chronic intestinal ischemia caused by intravenous cocaine use: Report of two cases and review of the literature. Journal of Vascular Surgery 23:4, 724-729
    CrossRef

  63. 63

    John M. Roll, Stephen T. Higgins, Alan J. Budney, Warren K. Bickel, Gary J. Badger. (1996) A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug and Alcohol Dependence 40:3, 195-201
    CrossRef

  64. 64

    S. T. Higgins, J. M. Roll, W. K. Bickel. (1996) Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology 123:1, 1-8
    CrossRef

  65. 65

    CHARLES SCHINDLER. (1996) Cocaine and cardiovascular toxicity. Addiction Biology 1:1, 31-47
    CrossRef

  66. 66

    Hollander, Judd E., . (1995) The Management of Cocaine-Associated Myocardial Ischemia. New England Journal of Medicine 333:19, 1267-1272
    Full Text

  67. 67

    Arthur J. Garvey, Kenneth D. Ward, Ryan E. Bliss, Bernard Rosner, Pantel S. Vokonas. (1995) Relation Between Saliva Cotinine Concentration, Cigarette Consumption, and Blood Pressure Among Smokers. The American Journal of Cardiology 76:1-2, 95-97
    CrossRef

  68. 68

    Judd E. Hollander, Robert. S. Hoffman. (1995) In response. Academic Emergency Medicine 2:4, 332-333
    CrossRef

  69. 69

    Giuseppe Gioia, Maristela Manuel, Joseph Russell, Jaekyeong Heo, Abdulmassih S. Iskandrian. (1995) Myocardial perfusion pattern in patients with cocaine-induced chest pain. The American Journal of Cardiology 75:5-6, 396-398
    CrossRef